55 related articles for article (PubMed ID: 15193434)
1. Overexpressed mutant G93A superoxide dismutase protects calcineurin from inactivation.
Li S; Wang X; Klee CB; Krieger C
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):156-61. PubMed ID: 15193434
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
[TBL] [Abstract][Full Text] [Related]
3. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
[TBL] [Abstract][Full Text] [Related]
4. Impaired Cu-Zn Superoxide Dismutase (SOD1) and Calcineurin (Cn) Interaction in ALS: A Presumed Consequence for TDP-43 and Zinc Aggregation in Tg SOD1
Kim JM; Billington E; Reyes A; Notarianni T; Sage J; Agbas E; Taylor M; Monast I; Stanford JA; Agbas A
Neurochem Res; 2019 Jan; 44(1):228-233. PubMed ID: 29299811
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between the formation of mitochondria-derived vacuoles and Lewy-body-like hyaline inclusions in G93A superoxide-dismutase-transgenic mice.
Sumi H; Nagano S; Fujimura H; Kato S; Sakoda S
Acta Neuropathol; 2006 Jul; 112(1):52-63. PubMed ID: 16642310
[TBL] [Abstract][Full Text] [Related]
6. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
7. Oxidative inactivation of calcineurin by Cu,Zn superoxide dismutase G93A, a mutant typical of familial amyotrophic lateral sclerosis.
Ferri A; Gabbianelli R; Casciati A; Celsi F; Rotilio G; Carrì MT
J Neurochem; 2001 Nov; 79(3):531-8. PubMed ID: 11701756
[TBL] [Abstract][Full Text] [Related]
8. Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis.
Sala G; Beretta S; Ceresa C; Mattavelli L; Zoia C; Tremolizzo L; Ferri A; Carrì MT; Ferrarese C
Neurochem Int; 2005 Feb; 46(3):227-34. PubMed ID: 15670639
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice.
Hu JH; Chernoff K; Pelech S; Krieger C
J Neurochem; 2003 Apr; 85(2):422-31. PubMed ID: 12675918
[TBL] [Abstract][Full Text] [Related]
10. Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin.
Volkel H; Scholz M; Link J; Selzle M; Werner P; Tunnemann R; Jung G; Ludolph AC; Reuter A
FEBS Lett; 2001 Aug; 503(2-3):201-5. PubMed ID: 11513882
[TBL] [Abstract][Full Text] [Related]
11. The familial amyotrophic lateral sclerosis-associated amino acid substitutions E100G, G93A, and G93R do not influence the rate of inactivation of copper- and zinc-containing superoxide dismutase by H2O2.
Liochev SI; Chen LL; Hallewell RA; Fridovich I
Arch Biochem Biophys; 1998 Apr; 352(2):237-9. PubMed ID: 9587411
[TBL] [Abstract][Full Text] [Related]
12. Do posttranslational modifications of CuZnSOD lead to sporadic amyotrophic lateral sclerosis?
Bredesen DE; Ellerby LM; Hart PJ; Wiedau-Pazos M; Valentine JS
Ann Neurol; 1997 Aug; 42(2):135-7. PubMed ID: 9266721
[No Abstract] [Full Text] [Related]
13. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis.
Solomon JN; Lewis CA; Ajami B; Corbel SY; Rossi FM; Krieger C
Glia; 2006 May; 53(7):744-53. PubMed ID: 16518833
[TBL] [Abstract][Full Text] [Related]
14. Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice.
Huang QY; Yu L; Ferrante RJ; Chen JF
Neurosci Lett; 2007 May; 418(2):175-80. PubMed ID: 17418947
[TBL] [Abstract][Full Text] [Related]
15. Is ALS caused by an altered oxidative activity of mutant superoxide dismutase?
Bush AI
Nat Neurosci; 2002 Oct; 5(10):919; author reply 919-20. PubMed ID: 12352974
[No Abstract] [Full Text] [Related]
16. [ALS models by transgenic animals].
Aoki M; Nagai M; Kato M; Itoyama Y
No To Shinkei; 2001 Sep; 53(9):799-807. PubMed ID: 11596474
[No Abstract] [Full Text] [Related]
17. Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits.
Petrik MS; Wilson JM; Grant SC; Blackband SJ; Tabata RC; Shan X; Krieger C; Shaw CA
Neuromolecular Med; 2007; 9(3):216-29. PubMed ID: 17914180
[TBL] [Abstract][Full Text] [Related]
18. Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Shan X; Vocadlo DJ; Krieger C
Neurosci Lett; 2012 May; 516(2):296-301. PubMed ID: 22521585
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase.
Ferri A; Gabbianelli R; Casciati A; Paolucci E; Rotilio G; Carrì MT
J Neurochem; 2000 Aug; 75(2):606-13. PubMed ID: 10899935
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressant FK506 does not exert beneficial effects in symptomatic G93A superoxide dismutase-1 transgenic mice.
Anneser JM; Gmerek A; Gerkrath J; Borasio GD; Heumann R
Neuroreport; 2001 Aug; 12(12):2663-5. PubMed ID: 11522944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
